Jusot, Viviane http://orcid.org/0000-0002-7747-8788
Chimimba, Frider
Dzabala, Nettie http://orcid.org/0000-0003-3655-0736
Menang, Olga
Cole, Joy
Gardiner, Gregory http://orcid.org/0000-0002-4379-2613
Ofori-Anyinam, Opokua http://orcid.org/0000-0001-8099-6837
Oladehin, Olakunle
Sambakunsi, Cecilia
Kawaye, Mphatso
Stegmann, Jens-Ulrich http://orcid.org/0000-0002-3792-4368
Guerra Mendoza, Yolanda http://orcid.org/0000-0002-4001-7662
Funding for this research was provided by:
GlaxoSmithKline Biologicals SA
Article History
First Online: 1 April 2020
Change Date: 31 March 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40264-021-01064-0
Compliance with Ethical Standards
:
: This work was supported by GlaxoSmithKline Biologicals SA. GlaxoSmithKline Biologicals SA provided financial support, including the salaries of a dedicated national PV coordinator and PV data manager, logistics for training and mentoring HCPs, and improvement of the national PV centre. GlaxoSmithKline Biologicals SA also covered the costs associated with the development and publishing of the present manuscript.
: VJ, JC, GG, OO-A, OO, J-US and YGM are employees of the GSK group of companies. OO-A, YGM and J-US hold shares in the GSK group of companies. YGM reports personal fees from GSK, outside the submitted work. CS reports a grant from the GSK group of companies to conduct this study. FC, ND, OM and MK report no conflict of interest.
: Ethical approval was not required for this work.
: Data sharing not applicable to this article as no datasets were generated or analysed during the current study.